Improvement in high-density lipoprotein cholesterol in people with HIV who switched from a tenofovir alafenamide-containing regimen to cabotegravir plus rilpivirine

Improvement in high-density lipoprotein cholesterol in people with HIV who switched from a tenofovir alafenamide-containing regimen to cabotegravir plus rilpivirine / Muccini, C.; Diotallevi, S.; Lolatto, R.; Piromalli, G.; Spagnuolo, V.; Castagna, A.. - In: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. - ISSN 0924-8579. - 64:4(2024). [10.1016/j.ijantimicag.2024.107312]